NU-BROMOCRIPTINE DIN 02230638
Status: Cancelled (Unreturned Annual)
Holder: NU-PHARM INC
Molecule: BROMOCRIPTINE (BROMOCRIPTINE MESYLATE)
Health Canada record
| Active ingredient(s) | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) 5.0 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G02CB01 BROMOCRIPTINE |
| Original market date | |
| Current status date | 28-Mar-2018 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BROMOCRIPTINE (BROMOCRIPTINE MESYLATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02230454 | BROMOCRIPTINE | AA PHARMA INC | Capsule | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) 5 MG | Marketed |
| 02087324 | BROMOCRIPTINE | AA PHARMA INC | Tablet | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) 2.5 MG | Marketed |
| 02238192 | BROMOCRIPTINE | PHARMEL INC | Tablet | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) 2.5 MG | Cancelled Post Market |
| 02238193 | BROMOCRIPTINE | PHARMEL INC | Capsule | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) 5 MG | Cancelled Post Market |
| 02153378 | BROMOCRIPTINE-2.5 - TAB 2.5MG | PRO DOC LIMITEE | Tablet | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) 2.5 MG | Cancelled Post Market |
| 02230719 | BROMOCRIPTINE-5 | PRO DOC LIMITEE | Capsule | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) 5 MG | Cancelled Post Market |
| 02244639 | CO BROMOCRIPTINE CAPSULES 5MG | COBALT PHARMACEUTICALS COMPANY | Capsule | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) 5 MG | Cancelled Pre Market |
| 02244640 | CO BROMOCRIPTINE TABLETS 2.5MG | COBALT PHARMACEUTICALS COMPANY | Tablet | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) 2.5 MG | Cancelled Pre Market |
| 02238636 | DOM-BROMOCRIPTINE | DOMINION PHARMACAL | Tablet | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) 2.5 MG | Cancelled Post Market |
| 02238637 | DOM-BROMOCRIPTINE | DOMINION PHARMACAL | Capsule | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) 5 MG | Cancelled Post Market |
| 02230637 | NU-BROMOCRIPTINE | NU-PHARM INC | Tablet | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) 2.5 MG | Cancelled (Unreturned Annual) |
| 00568643 | PARLODEL CAP 5MG | NOVARTIS PHARMACEUTICALS CANADA INC | Capsule | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) 5 MG | Cancelled Post Market |
| 00371033 | PARLODEL TAB 2.5MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) 2.5 MG | Cancelled Post Market |
| 02236949 | PMS-BROMOCRIPTINE | PHARMASCIENCE INC | Capsule | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) 5 MG | Cancelled Post Market |
| 02231702 | PMS-BROMOCRIPTINE | PHARMASCIENCE INC | Tablet | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) 2.5 MG | Cancelled Post Market |
| 00842680 | SYN-BROMOCRIPTINE CAP 5MG | SYNCARE PHARMACEUTICAL INC. | Capsule | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) 5 MG | Cancelled Post Market |
| 00842672 | SYN-BROMOCRIPTINE TAB 2.5MG | SYNCARE PHARMACEUTICAL INC. | Tablet | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) 2.5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 3322 | 1997-02-25 | New Drug Submission (NDS) |